Physician profile
Julia S Samaddar
NPI 1477817369
$1,967.81
in general payments reported to CMS, 2019-2025
23 companies · $630 in 2025
The $630 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.68 · 2020: $81.31 · 2021: $180 · 2022: $86.99 · 2023: $454 · 2024: $498 · 2025: $630.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,496 · Education: $85.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,495.67 |
| Education | $85.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $337.56 | 2023-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $294.90 | 2019-2023 | Lo Loestrin Fe |
| Biogen, INC. | $260.34 | 2024-2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $170.82 | 2023-2025 | |
| Millicent US INC | $129.40 | 2024-2025 | Intrarosa, Femlyv |
| Daiichi Sankyo INC. | $99.75 | 2020-2021 | |
| Evofem Biosciences, INC. | $83.44 | 2024-2025 | Solosec, Phexx, Phexxi |
| Bayer Healthcare Pharmaceuticals INC. | $74.43 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $65.79 | 2023-2025 | Gardasil 9, Gardasil |
| Organon LLC | $53.97 | 2024 | |
| Aspira Women'S Health INC | $44.35 | 2023 | Ova1 |
| Shield Therapeutics INC | $42.14 | 2024 | |
| Exeltis, USA INC. | $41.25 | 2024-2025 | Slynd |
| Applied Medical Resources Corporation | $40.54 | 2024 | |
| Sumitomo Pharma America, INC. | $40.36 | 2023-2025 | Myfembree |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $38.85 | 2024 | |
| Myovant Sciences INC. | $35.21 | 2021-2022 | |
| Meditrina | $26.13 | 2024-2025 | |
| Convatec INC. | $22.61 | 2023 | |
| Smith+Nephew, INC. | $19.29 | 2025 | Pico 14, Pico 7 |
| Optumhealth Care Solutions, LLC | $17.88 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Mylan Pharmaceuticals INC. | $14.88 | 2021 | |
| Hologic Sales and Service, LLC | $13.92 | 2025 | Thinprep 2000 Processor, Aptima |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Samaddar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.